The value of a High-Volume Image-Guided Injections (HVIGI) in chronic midportion Achilles tendinopathy: a double-blind, placebo-controlled, randomised clinical trial - HAT-study

Medisch Centrum Haaglanden0 个研究点目标入组 80 人开始时间: 2015年3月5日最近更新: 2019年11月25日

适应症

试验速览

暂无简介。

•- Age 18-70 years.
•- Clinical diagnosis of chronic midportion Achilles tendinopathy: Painfull swelling of the Achilles tendon, 2-7 cm proximal to it’s calcaneal insertion.
•- Non-response to eccentric excercise program for 6 weeks.
•- Painfull Achilles tendon for more than 2 months.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 80
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•- Clinical suspicion of insertional disorders.
•- Clinical suspicion of Achilles tendon rupture.
•- Clinical suspicion of plantar flexor tenosynovitis.
•- Clinical suspicion of peroneal tendinopathy or subluxation.
•- Clicical suspicion of sural nerve pathology.
•- Condition of the Achilles tendon caused by medication, such as quinolones and statins.
•- Known to have the following disorders: spondylarthropathy, gout, hyperlipidemia, rheumatoid arthritis and sarcoïdosis.
•- Inability to perform a heavy load eccentric exercise program.
•- Recently prescribed drugs (within 2 years) with a putative effect on symptoms and tendon healing (quinolone antibiotics, corticosteroids).
•- Presence of pregancy.
•- Previous Achilles tendon rupture.
•- Patient has received surgical intervention for his injury.
•- A medical condition that would affect safety of injection (e.g. peripheral vascular disease, use of anticoagulant medication)
•- Inability to give informed consent.
•- Participation in other concomitant treatment programs.
•- Patient has already one side included in this study.
•- Patient does not wish, for whatever reason, to undergo one of the two treatments.

发起方